Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:FMC NYSE:PKI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFMCFMC$40.66+3.4%$40.91$32.83▼$67.75$5.08B0.752.00 million shs1.57 million shsPKIRevvity$127.73$113.46▼$170.00$14.57B1.1851,117 shs1.63 million shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFMCFMC0.00%+8.67%-3.82%+6.34%-36.43%PKIRevvity0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFMCFMC4.3656 of 5 stars3.23.02.50.03.92.51.3PKIRevvity3.767 of 5 stars0.00.01.73.50.61.74.4Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFMCFMC 2.31Hold$49.5821.93% UpsidePKIRevvity 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest FMC and PKI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/13/2025FMCFMCBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$49.00 ➝ $48.008/1/2025FMCFMCRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$47.00 ➝ $42.008/1/2025FMCFMCMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$46.00 ➝ $42.007/31/2025FMCFMCUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$45.00 ➝ $44.007/14/2025FMCFMCKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$53.00 ➝ $61.007/10/2025FMCFMCRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Perform ➝ Sector Perform$40.00 ➝ $47.007/9/2025FMCFMCUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$41.00 ➝ $45.007/7/2025FMCFMCBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$48.00 ➝ $49.006/23/2025FMCFMCWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$41.00 ➝ $50.00(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFMCFMC$4.25B1.20$4.91 per share8.29$35.45 per share1.15PKIRevvity$3.31B0.00N/A9.88$58.49 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFMCFMC$341.10M$0.8050.8310.291.262.42%9.36%3.51%11/4/2025 (Estimated)PKIRevvity$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/ALatest FMC and PKI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025FMCFMC$0.59$0.69+$0.10$0.53$995.15 million$1.05 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFMCFMC$2.325.71%N/A290.00%N/APKIRevvity$0.280.24%N/A3.65%N/ALatest FMC and PKI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/16/2025FMCFMCquarterly$0.585.48%9/30/20259/30/202510/16/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFMCFMC0.741.531.14PKIRevvity0.482.432.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFMCFMC91.86%PKIRevvity85.22%Insider OwnershipCompanyInsider OwnershipFMCFMC0.67%PKIRevvity0.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFMCFMC5,700124.91 million124.08 millionOptionablePKIRevvity16,700126.41 million125.76 millionOptionableFMC and PKI HeadlinesRecent News About These CompaniesRevvity, Inc. Earnings Call: Mixed Sentiment and Strategic MovesJuly 28, 2025 | tipranks.comWhat 9 Analyst Ratings Have To Say About RevvityJune 28, 2025 | benzinga.comRevvity, formerly PerkinElmer, moves to newer, smaller Waltham HQNovember 29, 2024 | bostonglobe.comBRevvity Ramps Up R&D Spending Since PerkinElmer SplitOctober 15, 2024 | msn.comRevvity, Inc. (RVTY)July 19, 2024 | finance.yahoo.comRevvity Inc PKIFebruary 13, 2024 | morningstar.comMRevvity revenue drops 17% in first year after PerkinElmer spinout, thanks to COVID testing declinesFebruary 1, 2024 | fiercebiotech.comFPerkinElmer buys Covaris to boost next-gen life sciences offeringsDecember 4, 2023 | mmm-online.comMPerkinElmer picks up Covaris’ sample prep portfolio in New Mountain-led dealDecember 4, 2023 | fiercebiotech.comFRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCIDDecember 1, 2023 | businesswire.comRevvity and Sciex Collaborate To Provide Innovative Neonatal Mass Spectrometry SolutionNovember 1, 2023 | technologynetworks.comTRevvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, PredictionsNovember 1, 2023 | benzinga.comRevvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis SolutionsOctober 29, 2023 | finance.yahoo.comRevvity, IncAugust 3, 2023 | moneycontrol.comRevvity (RVTY) Beats on Q2 Earnings, Lowers '23 EPS ViewAugust 2, 2023 | finance.yahoo.comRevvity (NYSE: PKI)August 1, 2023 | fool.comRevvity (RVTY) to Report Q2 Earnings: What's in the Cards?July 31, 2023 | finance.yahoo.comPerkinElmer Completes Transformation to Become RevvityMay 19, 2023 | finance.yahoo.comRevvity Announces New License Agreement for Next-Generation Base Editing TechnologyMay 18, 2023 | finance.yahoo.comJ.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)May 16, 2023 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFMC and PKI Company DescriptionsFMC NYSE:FMC$40.66 +1.32 (+3.37%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$40.70 +0.03 (+0.08%) As of 08/22/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.Revvity NYSE:PKIRevvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Workday: Institutions Are Buying This Stock, Shouldn’t You? Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access